Evaluation of the Pharmacokinetic Drug–Drug Interaction between Micronized Fenofibrate and Pitavastatin in Healthy Volunteers

Dyslipidemia is a major risk factor for development of atherosclerosis and cardiovascular disease (CVD). Effective lipid-lowering therapies has led to CVD risk reduction. This study evaluated the possible pharmacokinetic interactions between fenofibrate, a peroxisome proliferators-activated receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hae Won, Kang, Woo Youl, Jung, Wookjae, Gwon, Mi-Ri, Cho, Kyunghee, Yang, Dong Heon, Yoon, Young-Ran, Seong, Sook Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557955/
https://www.ncbi.nlm.nih.gov/pubmed/32932576
http://dx.doi.org/10.3390/pharmaceutics12090869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557955/
https://www.ncbi.nlm.nih.gov/pubmed/32932576
http://dx.doi.org/10.3390/pharmaceutics12090869

Ejemplares similares